Characterization of the pediatric patients with Guillain-Barre
Keywords:
Diseases of the nervous system, Rare diseases, Immunology, Polyradiculoneuropathy, Rehabilitation, Guillain Barre syndromeAbstract
Introduction: Guillain-Barré syndrome is a neurological disease that includes a group of autoimmune disorders; it is considered the most frequent cause of polyneuropathy in childhood.
Objective: to characterize pediatric patients with Guillain-Barré treated at the Roberto Rodríguez Fernández General Teaching Hospital, Moron, Ciego de Avila.
Method: an observational, descriptive, longitudinal retrospective study was carried out in the period from January 2018 to January 2020. The universe consisted of 12 patients, working with all of them. Descriptive statistics were used and absolute and relative percentage frequencies were used as a summary measure of the information.
Results: the most represented age group was 0-4 years with 6 patients and the male sex was present in 58,3 %. All 12 patients had muscle strength and mobility impairment. 41,7 % recovered within the first six months and as a consequence after treatment, 25% suffered cavus foot.
Conclusions: a predominance was observed in the age group 0-4 years, male and white skin color. The predominant clinical symptoms were decreased muscle strength, mobility, and some activities of daily living. The most used rehabilitation treatment was functional training for activities of daily living. After the application of the clinical and rehabilitative treatment, recovery was observed in most of the patients in the first 6 months, and only some cases suffered sequelae.
Downloads
References
1. Jacobs BC, van den Berg B, Verboon C. Estudio internacional de resultados del síndrome de Guillain-Barré: protocolo de un estudio de cohorte observacional prospectivo sobre predictores clínicos y biológicos del curso de la enfermedad y el resultado del síndrome de Guillain-Barré J PeripherNervSyst. [Internet] 2017[citado 2021 May. 03]; 22 (2): 68-76. Disponible en: https://doi.org/10.1111/jns.12209.
2. Rebolledo-García D, González-Vargas PO, Salgado-Calderón I. Síndrome de Guillain-Barré: viejos y nuevos conceptos. Med. interna Méx. [Internet]. 2018 Feb [citado 2019 Sep. 25]; 34(1): 72-81. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S018648662018000100009&lng=es
3. Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, et al. Diagnóstico y manejo del síndrome de Guillain-Barré en diez pasos. NatRev Neurol. [Internet] 2019 [citado 2021 May. 03]; 15: 671-83. Disponible en: https://doi.org/10.1038/s41582-019-0250-9
4. Phillips-Morales Ó. Actualización en el Síndrome de Guillain-Barré.Rev. Méd. Sinergia. [Internet] 2019 [citado 2021 Mar. 12];4(11):290. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=7148915
5. Burga-Bravo A, Madalengoitia-Rangel S. Características clínica y epidemiológicas de pacientes con diagnóstico síndrome de Guillain Barré atendidos en el servicio de medicina física y rehabilitación en el año 2019. Revista Del Cuerpo Médico Del HNAAA. [Internet] 2020 [citado 2021 May. 03]; 13(1):32-36. Disponible en: https://doi.org/10.35434/rcmhnaaa.2020.131.619
6. Loayza-Alarico, Manuel J., Cruz-Vargas, De la Jhony A y Alatrista, María del SocorroSíndrome de Guillain-Barré, brote epidémico en el Perú en junio de 2019. Salud Pública de México. [Internet] 2020 [citado 2021 May 03]; 61(5): 556-557. Disponible en: https://doi.org/10.21149/10731.
7. Esposito S, Longo MR. Guillain-Barré syndrome. AutoimmunRev [Internet]. 2017 Jan [citado 2019 Sep. 25];16(1):96-101.Disponible en: https://doi.org/10.1016/j.autrev.2016.09.022
8. Chung A, Deimling M. Guillain-Barré Syndrome. PediatrRev [Internet]. 2018 Jan [citado 2019 Sep.25];39(1):53-54. Disponible en: https://doi.org/10.1542/pir.2017-0189
9. Munayco-César V, Soto-Cabezas MG, Reyes-Mary F, Arica-Gutiérrez JA, Napanga-Saldaña O. Epidemiología del síndrome de Guillain-Barré en el Perú. Rev. perú. med. exp. salud publica [Internet]. 2019 Ene [citado 2021 May 04]; 36(1): 10-16. Disponible en: http://dx.doi.org/10.17843/rpmesp.2019.361.3729.
10. Pazo-Mollineda PL, Cisneros-Perdomo V, Bautista-Atienzo W, Aruca-Sierra D, Mendoza-Rodríguez S. Efectividad del CON-TREX ® MJ y THERA Trainertigo 510 en la evaluación y rehabilitación del síndrome Guillain Barré. Rev. Cub. Med. Física y Rehabilitación, [Internet] 2017[citado 2021 May. 03]; 9(1): [aprox. 15p]. Disponible en: http://www.revrehabilitacion.sld.cu/index.php/reh/article/view/195/273
11. Vigil-Zulueta IA, Guerra-Santana A, Ochoa-Undangarain L, Hernández-Zayas MS, Domínguez-Osorio CA. Rehabilitación de niños y adolescentes con síndrome de Guillain- Barré. MEDISAN [Internet]. 2012 oct [citado 2019 Sep. 25]; 16(10): 1513-1523. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S102930192012001000006&lng=es.
12. Verboon C, Doets AY, Galassi G y col. Práctica de tratamiento actual del síndrome de Guillain-Barré. Neurología. [Internet] 2019[citado 2021 May. 03]; 93: e59-e76. Disponible en: https://doi.org/10.1212/WNL.0000000000007719.
13. Del Sol Serrallonga N. Comportamiento clínico-terapéutico del síndrome Guillain-Barré en niños. Rev. AMC [Internet]. 2016 [citado 2019 Sep. 25]; 20(4). Disponible en: http://www.revistaamc.sld.cu/index.php/amc/article/view/4143/2479
14. Rigo D, Ross C, Hofstätter LM, Ferreira M, Azevedo F, Pompilio L. Síndrome de Guillain Barré: perfil clínico epidemiológico y asistencia de enfermería. Enferm. glob. [Internet]. 2020 [citado 2021 May 04]; 19(57): 346-389. Disponible en: https://dx.doi.org/eglobal.19.1.366661.
15. Ballón-Manrique B, Campos-Ramos N. Características clínicas y paraclínicas del Síndrome de Guillain-Barré en el Hospital Regional Lambayeque. RevNeuropsiquiatr [Internet]. 2017 Ene [citado 2021 May 04]; 80(1): 22-26. Disponible en: http://dx.doi.org/10.20453/rnp.v80i1.3056.
16. Doets AY, Hughes RA, Brassington R, Hadden RD, Pritchard J. Tratamiento farmacológico diferente a los corticosteroides, inmunoglobulina intravenosa e intercambio de plasma para el síndrome de Guillain-Barré. Cochrane DatabaseSyst Rev. [Internet] 2020; [citado 2021 May. 03] 1: CD008630. Disponible en: https://doi.org/10.1002/14651858.CD008630.pub5
17. Zaldívar JM, Sosa J, García D. Miller Fisher. A propósito de un caso. Univ. Méd. Pinareña [Internet]. 2011 Abr-jun [citado 2019 Sep. 25]; 15(2): 51-53. Disponible en: http://scielo.sld.cu/scielo.php?pid=S156131942011000200024&script=sci_arttext
18. Alva-Diaz C, Morib N, Pacheco-Barriosa K, Velásquez-Rimachia V, Rivera-Torrejona O. Guía de práctica clínica para el diagnóstico y tratamiento del paciente con síndrome de Guillain-Barré. Rev. Neurolog. Argentina. [Internet] 2020 [citado 2021 May 04]; 12(1):36-48. Disponible en: https://doi.org/10.1016/j.neuarg.2019.09.006
19. González-Vidal D, Aguilera-Pacheco OR, Ruiz-Miyares FJ, Casamajor-Castillo MA, Parrón-Cardero I. Síndrome de Guillain-Barré en la infancia. MEDISAN [Internet]. May 2014 [citado 2019 Oct 07];18(5): pp.613-620. Disponible en: http://scieloprueba.sld.cu/ scielo.php?script=sci_arttext&pid=S102930192014000500004&lng=es
20. Silva MA, Palacios E, Castillo GA, Monsalve JA, Leal Castaño LF. Secuelas neurológicas del síndrome de Guillain-Barré en pacientes adultos. Repert. Med. Cir. [Internet]. 27 de febrero de 2020 [citado 2021 May 04];29(3):185-91. Disponible en: https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/972
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: authors retain their copyright and grant the journal the right of first publication of their work, which is simultaneously subject to the Creative Commons Attribution-NonCommercial 4.0 International License that allows third parties to share the work as long as the author and first publication in this journal are indicated, for non-commercial use. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional telematic archive or publishing it in a monographic volume) as long as the initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work via the Internet (e.g., in institutional telematic archives, in their web page or in Pre-print servers) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The Open Access Effect).
